RECORD // Company

Adia Med, Inc.

Formerly: Adia Nutrition, Inc.; PivX Solutions, Inc.; DRILLING INC

Built 2026-11-22T03:30:49Z from public sources · JSON · Open the company profile

ASK THE RECORDS

Ask

COMPANY

Records for this company (1 joined by official identifier)

Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.

SEC EDGAR (1)

4 VALUES · 10-Q · EACH LINKS TO ITS FILING

Latest quarter

Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-16 · accession 0001683168-26-008830

ItemValuePeriodFormFiledAccessionReport
Revenue$454,3853 months ended 2026-09-3010-Q2026-11-160001683168-26-0088302026-11-22 03:30 UTCReport an error
Net income (loss)$-53,0153 months ended 2026-09-3010-Q2026-11-160001683168-26-0088302026-11-22 03:30 UTCReport an error
Interest expense$13,9903 months ended 2026-09-3010-Q2026-11-160001683168-26-0088302026-11-22 03:30 UTCReport an error
Cash and cash equivalents$1,137,818at 2026-09-3010-Q2026-11-160001683168-26-0088302026-11-22 03:30 UTCReport an error

Negative as reported in the filing.

Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.

IDS

Identifiers

SEC CIK
0001160420
Ticker
ADIA
EIN
870675769
CUSIP
000132357
Record ID
sx:sec:0001160420

OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA

Open in

Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

19 FACTS · EACH LINKS TO ITS FILING

Facts

FactValueAs ofSourceRetrievedReport
SEC entity typeoperating2026-11-16SEC EDGAR company profile2026-11-22 03:30 UTCReport an error
SIC industry2833 Medicinal Chemicals & Botanical Products2026-11-16SEC EDGAR company profile2026-11-22 03:30 UTCReport an error
State of incorporationNV2026-11-16SEC EDGAR company profile2026-11-22 03:30 UTCReport an error
Fiscal year end (MMDD)12312026-11-16SEC EDGAR company profile2026-11-22 03:30 UTCReport an error
Business address4421 GABRIELLA LANE, WINTER PARK, FL, 327922026-11-16SEC EDGAR company profile2026-11-22 03:30 UTCReport an error
ExchangesOTC2026-11-16SEC EDGAR company profile2026-11-22 03:30 UTCReport an error
Revenue (fiscal year ended 2025-12-31)$700,5082025-12-3110-K, XBRL Revenues2026-11-22 03:30 UTCReport an error
Net income (loss) (fiscal year ended 2025-12-31)$-395,4642025-12-3110-K, XBRL NetIncomeLoss2026-11-22 03:30 UTCReport an error
Total assets (at 2025-12-31)$594,8262025-12-3110-K, XBRL Assets2026-11-22 03:30 UTCReport an error
Stockholders' equity (at 2025-12-31)$-257,6742025-12-3110-K, XBRL StockholdersEquity2026-11-22 03:30 UTCReport an error
Cash and cash equivalents (at 2025-12-31)$79,3922025-12-3110-K, XBRL CashAndCashEquivalentsAtCarryingValue2026-11-22 03:30 UTCReport an error
Operating cash flow (fiscal year ended 2025-12-31)$-179,2282025-12-3110-K, XBRL NetCashProvidedByUsedInOperatingActivities2026-11-22 03:30 UTCReport an error
Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31)$13,2002025-12-3110-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment2026-11-22 03:30 UTCReport an error
Operating lease liabilities (at 2025-12-31)$109,8682025-12-3110-K, XBRL OperatingLeaseLiability2026-11-22 03:30 UTCReport an error
8-K Item 1.01, Entry into a Material Definitive Agreement (filed 2026-10-19)On October 13, 2026, Adia Med, Inc. (the “Company”) entered into a Membership Interest Purchase Agreement (the “Agreement”) with Larry A. Powalisz, the Company’s Chief Executive Officer (the “Buyer”), Adia Labs LLC, a Florida limited liability company (the “LLC”), Live Oak Health LLC d/b/a QCM Biologics (“Live Oak”), and the Company’s independent directors Monica Sher, M.D. and Richard Edwards, D.O. Pursuant to the Agreement, the Company sold seven (7) units of membership interest (the “Purchased Units”) in the LLC to the Buyer for an aggregate purchase price of Three Hundred Fifty Thousand and 00/100 Dollars ($350,000.00), payable entirely in cash. The Purchased Units constitute a seven…2026-10-19SEC EDGAR 8-K 0001683168-26-007951 (text as filed, excerpt)2026-11-22 03:30 UTCReport an error
8-K Item 1.02, Termination of a Material Definitive Agreement (filed 2026-10-13)On October 9, 2026, Adia Med, Inc. (the “Company”) fully repaid and discharged its unsecured revolving line of credit facility originally entered into on June 30, 2024, between Larry Powalisz, Chief Executive Officer of the Company, as lender (the “Lender”), and the Company (and its relevant subsidiaries, as applicable), as borrower. The Facility had been increased over time to a commitment of $1,000,000 by the Lender, to best accommodate the growth needs of the Company, and bore interest at 6% per annum calculated daily. In satisfaction of the obligation to the Lender, the Company made the following payments to the Lender: · October 7, 2026: $500,000; · October 9, 2026: $434,970.94 (of…2026-10-13SEC EDGAR 8-K 0001683168-26-007770 (text as filed, excerpt)2026-11-22 03:30 UTCReport an error
8-K Item 1.01, Entry into a Material Definitive Agreement (filed 2026-10-06)On September 30, 2026, Adia Med, Inc. (the “Company”), Adia Labs LLC, a Florida limited liability company and subsidiary of the Company (the “Labs Company”), and Live Oak Health LLC, a Florida limited liability company doing business as QCM Biologics (“Buyer”), entered into a Membership Interest Purchase Agreement (the “Purchase Agreement”). David Konn is the sole member and manager of Buyer. Buyer is not, to the Company’s knowledge, an affiliate of the Company. Under the Purchase Agreement, the Company agreed to sell, and Buyer agreed to purchase, 30 units of membership interest in the Labs Company (the “Purchased Units”), representing 30% of the 100 units issued and outstanding, at…2026-10-06SEC EDGAR 8-K 0001683168-26-007632 (text as filed, excerpt)2026-11-22 03:30 UTCReport an error
8-K Item 2.01, Completion of Acquisition or Disposition of Assets (filed 2026-10-06)The information in Item 1.01 of this Current Report on Form 8-K is incorporated into this Item 2.01 by reference. On September 30, 2026, the Company completed the sale of the Purchased Units to Buyer on the terms described in Item 1.01. After closing, the Company owns 70 of the 100 issued units of the Labs Company, representing 70% of the economic interest, and Buyer owns 30 units, representing 30% of the economic interest. Each of the Company and Buyer holds 50% of the voting power. The Company’s common stock will continue to trade on the OTC Markets under the ticker symbol “ADIA.” The sale does not affect outstanding certificates for shares of the Company’s common stock.2026-10-06SEC EDGAR 8-K 0001683168-26-007632 (text as filed, excerpt)2026-11-22 03:30 UTCReport an error
8-K Item 8.01, Other Events (filed 2026-10-05)On September 28, 2026, Adia Med, Inc. (the “Company”) filed a Verified Complaint for Declaratory Judgement (the “Complaint”) in the Circuit Court of the Eighteenth Judicial Circuit in and for Seminole County, Florida, styled In Re Stock of ADIA MED, INC. v. Tydus Richards, Case No. 2026CA002155 (the “Action”). A copy of the Complaint is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The description of the Action in this Item 8.01 is qualified in its entirety by the Complaint. The Action is a declaratory-judgment proceeding seeking to quiet title in 29,059,792 shares of the Company’s non-preferred common stock (the “Subject Shares”). The…2026-10-05SEC EDGAR 8-K 0001683168-26-007624 (text as filed, excerpt)2026-11-22 03:30 UTCReport an error

EVERY DATED RECORD, NEWEST FIRST

Timeline

WHAT IS NOT HERE

Gaps

SOURCES AND LICENSE

Sources

CC BY 4.0 -- credit Seraphix Systems.

API

Use this record

Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.